the aid library

Key
Resources
Clinical
Guidelines
Women & Child
Health
Pharmacy &
Technologies
Public
Health
Capacity
Building
COUNTRIES
TOOLBOXES
- NCDs
- NTDs
- Planetary Health
- Mental Health
- AMR
- Caregiver
- Pharmacy
- COVID-19
- Global Health Education
- Ebola
- Natural Hazards
- Conflict
- Zika
- TB
- Cholera
- HIV
- Polio
- Rapid Response
- Refugee
- Disability
- Specific Hazards
- Social Ethics
- Health Financing Toolbox

Middle East and North Africa
West and Central Africa
East and Southern Africa
South–East Asia Region
Western Pacific Region
Eastern Europe and Central Asia
Latin America and the Carribbean
Western and Central Europe
North America

Key
Resources

Clinical
Guidelines

Women & Child
Health

Pharmacy &
Technologies

English

English Deutsch Español Français русский عربى

My MEDBOX Register

Login
Register
English
- English
- Deutsch
- Español
- Français
- русский
- عربى

Search database

Create your MEDBOX

LIST OPTIONS

Filter

Filtered Results: 48

Text search: Zhu, Anna

Featured

Recommendations

New Publications

Language

English

Russian

Spanish

German

French

Portuguese

Arabic

Thai

Document type

Guidelines

No document type

Studies & Reports

Manuals

Fact sheets

Training Material

Countries / Regions

Spain

Russia

Global

Kenya

Africa

Latin America and the Carribbean

Germany

Brazil

China

Mozambique

Asia

Eastern Europe and Central Asia

Portugal

Argentina

Uganda

Angola

India

Authors & Publishers

World Health Organization WHO

Ministerio de sanidad - España

AidData at William & Mary

and C. Hoffmann

Centro de Coordinación de Alertas y Emergencias Sanitarias

et al.

Kamps, B.S.

WHO

World Health Organization

A. Fuchs

Access Campaign, Médecins sans Frontières

B. Parks et al.

Bălă, G.P.

Bernard van Leer Foundation

BMC Infectious Diseases

Budreviciute, A.

Bulletin of the World Health Organization

Centro de Coordinación de Alertasy Emergencias Sanitarias

Chakaya, J.

Chu, D.K.

Damiati, S.

Dreher, A.

E. J. Abrams

E.A Akl, S. Duda, et al.

Environmental Science and Pollution Research

European Centre for Disease Prevention and Control (ECDC)

F. Zermoglio

Fuchs, A. and Öhler, H.

Gil, A.

Global Heart

Hijazi, Z.

Indian Council of Medical Research (ICMR)

International council of Nurses

J Acquir Immune Defic Syndr

J. Ananworanich

J. Ayieko, L. Abuogi, B. Simchowitz, et al.

Journal of Allergy and Clinical Immunology: Global

K.L.Ebi

Kamala Achu, Kathy Al Jubah, Svein Brodtkorb, et al.

Katie Murphy, Sandra Maignant, Laura Boone, Sarah Smith

Kengne, A.P. et al.

Kenya Ministry of Health

Khdr Sabir, D. et al.

Kirenga, B.J.

La Sociedad Argentina de Infectología S.A.D.I.

Lee J. Y., Marotzke J., et al.

Lee, V.

Liu Xiaoyun

M. Archary

M.N. Ngongondo

Makanjuola, A. et al.

Mental Health and Psychosocial Support Network

MHPSS.net

Ministry of health

Ministry of Health, Kenya

Ministry of Health, Republic of Uganda

Organisation Mondiale de la Santé OMS

P. Brouwers

Pan American Health Organisation PAHO

Pub Med

Râjnoveanu, R.M.

Robert-Koch-Institut RKI

Sliwa, K.

Tang, Shenglan

The Dag Hammarskjöld Foundation and ReAct

Tudorache, E. et al.

UNICEF

USAID

World Health Organization, Regional Office for South-East Asia

Yaria, J.

Yimer, G. et al.

Yuyun, M.F.

Zaidel, E.J.

Zhu, Anna

Артымук Н. В., Баев О. Р., Белокриницкая Т. Е. et al.

Всемирная организация здравоохранения

Всемирная организация здравоохранения (ВОЗ)

Всемирная организация здравоохранения (Европа)

Министерство здравоохранения Российской Федерации

Publication Years

1990-1999

2000-2009

2010-2019

2020-2025

Mental Health and COVID-19: Early evidence of the pandemic’s impact

World Health Organization WHO (2022) C_WHO

scientific brief, 2 March 2022

Download (130)

View PDF (214)

Add to my MEDBOX

Heat waves and human health

Lee, V.; F. Zermoglio; K.L.Ebi; et al. USAID (2019) C1

Emerging evidence and experience to inform risk management in a warming world

Download (102)

View PDF (120)

Add to my MEDBOX

COVID-19: Implications for People with Chagas Disease

Zaidel, E.J.; et al. (2020) CC

Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.

Add to my MEDBOX

Guía de profilaxis Antibiótica Quirúrgica

La Sociedad Argentina de Infectología S.A.D.I. (2017) C2

Las infecciones del sitio quirúrgico (ISQ) constituyen una de las Infecciones Asociadas al Cuidado de la Salud (IACS) más frecuentes que ponen en riesgo a los pacientes llevando muchas veces al fracaso del procedimiento quirúrgico. Con una incidencia mucho mayor en países de medianos y bajos ing...resos, representa un desafío de la práctica médica cotidiana que compromete la salud y la seguridad de los pacientes. La indicación de profilaxis primaria con antibióticos en relación a los procedimientos invasivos, tiene como objetivo disminuir la incidencia de infecciones con la consecuente disminución de la morbimortalidad debiendo utilizarse únicamente en aquellos procedimientos en los que hay evidencia de efectividad. Cabe destacar que la indicación inadecuada, tiene potenciales efectos adversos tales como infecciones por Clostridium difficile, emergencia de resistencia bacteriana, reacciones adversas a drogas e incremento de los costos en salud. La profilaxis antibiótica como complemento de una buena técnica quirúrgica, es una medida costo efectiva de prevención de las ISQ representando alrededor del 30% de la indicación de antibióticos entre los pacientes hospitalizados. Dado que en algunos estudios el uso inapropiado de antibióticos se ve reflejado en el 40 al 80% de las indicaciones médicas, desde la Comisión de Infecciones Asociadas al Cuidado de la Salud y Seguridad del Paciente de SADI hemos realizado una actualización de la evidencia disponible. Este documento es una acción complementaria al consenso “Prevención de Infección del Sitio Quirúrgico” realizado entre SADI y el Instituto Nacional de Epidemiología “J. Jara” durante el Congreso de SADI 2015. La posibilidad de contar con una guía actualizada de profilaxis quirúrgica adaptada a nuestro medio, constituye una herramienta de uso cotidiano por parte de los profesionales del equipo quirúrgico que permite la optimización de la utilización de fármacos restringiendo así la emergencia y diseminación de la resistencia bacteriana. Sin duda esperamos que pueda ser de utilidad para el equipo de salud. more

Download (184)

View PDF (158)

Add to my MEDBOX

Clinical management of COVID-19: living guideline, 23 June 2022 (Arabic)
recommended

World Health Organization WHO (2022) C_WHO

Update, 23 de junio de 2022

Download (37)

View PDF (48)

Add to my MEDBOX

Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective

Yuyun, M.F.; Sliwa, K.; Kengne, A.P. et al. Global Heart (2020) CC

Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...hat SSA is now at the dawn of the epidemiological transition with contemporary double burden of disease from NCDs and communicable diseases. In SSA, cardiovascular diseases (CVDs) are the most frequent causes of NCDs deaths, responsible for approximately 13% of all deaths and 37% of all NCDs deaths. Although ischemic heart disease (IHD) has been identified as the leading cause of CVDs mortality in SSA followed by stroke and hypertensive heart disease from statistical models, real field data suggest IHD rates are still relatively low. The neglected endemic CVDs of SSA such as endomyocardial fibrosis and rheumatic heart disease as well as congenital heart diseases remain unconquered. While the underlying aetiology of heart failure among adults in high-income countries (HIC) is IHD, in SSA the leading causes are hypertensive heart disease, cardiomyopathy, rheumatic heart disease, and congenital heart diseases. Of concern is the tendency of CVDs to occur at younger ages in SSA populations, approximately two decades earlier compared to HIC. Obstacles hampering primary and secondary prevention of CVDs in SSA include insufficient health care systems and infrastructure, scarcity of cardiac professionals, skewed budget allocation and disproportionate prioritization away from NCDs, high cost of cardiac treatments and interventions coupled with rarity of health insurance systems. This review gives an overview of the descriptive epidemiology of CVDs in SSA, while contrasting with the HIC and highlighting impediments to their management and making recommendations. more

Add to my MEDBOX

Air pollution exposure—the (in)visible risk factor for respiratory diseases

Bălă, G.P.; Râjnoveanu, R.M.; Tudorache, E. et al. Environmental Science and Pollution Research (2021) CC

There is increasing interest in understanding the role of air pollution as one of the greatest threats to human health worldwide. Nine of 10 individuals breathe air with polluted compounds that have a great impact on lung tissue. The nature of the relationship is complex, and new or updated data are... constantly being reported in the literature. The goal of our review was to summarize the most important air pollutants and their impact on the main respiratory diseases (chronic obstructive pulmonary disease, asthma, lung cancer, idiopathic pulmonary fibrosis, respiratory infections, bronchiectasis, tuberculosis) to reduce both short- and the long-term exposure consequences. We considered the most important air pollutants, including sulfur dioxide, nitrogen dioxide, carbon monoxide, volatile organic compounds, ozone, particulate matter and biomass smoke, and observed their impact on pulmonary pathologies. We focused on respiratory pathologies, because air pollution potentiates the increase in respiratory diseases, and the evidence that air pollutants have a detrimental effect is growing. It is imperative to constantly improve policy initiatives on air quality in both high- and low-income countries. more

Add to my MEDBOX

The burden of severe asthma in sub-Saharan Africa: Findings from the African Severe Asthma Project

Kirenga, B.J.; Chakaya, J.; Yimer, G. et al. Journal of Allergy and Clinical Immunology: Global (2024) CC

Severe asthma is associated with high morbidity, mortality, and health care utilization, but its burden in Africa is unknown. This article wants to determine the burden (prevalence, mortality, and activity and work impairment) of severe asthma in 3 countries in East Africa: Uganda, Kenya, and Ethio...pia using the American Thoracic Society/European Respiratory Society case definition of severe asthma. more

Create your own dev-medbox
Login

Home
Contact
Data privacy
Legal notice
FAQ
About
Sitemap

A Project by

dev-medbox @ 2025

Mental Health and COVID-19: Early evidence of the pandemic’s impact

Heat waves and human health

COVID-19: Implications for People with Chagas Disease

Guía de profilaxis Antibiótica Quirúrgica

Clinical management of COVID-19: living guideline, 23 June 2022 (Arabic) recommended

Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective

Air pollution exposure—the (in)visible risk factor for respiratory diseases

The burden of severe asthma in sub-Saharan Africa: Findings from the African Severe Asthma Project

Clinical management of COVID-19: living guideline, 23 June 2022 (Arabic)
recommended